This paper is only available as a PDF. To read, Please Download here.
Diabetes mellitus is recognized as a risk factor for compromised wound healing. This study examines leukocyte infiltration and the appearance of tumor necrosis factor-α (TNF) and IL-6 in wound chambers implanted in normal and streptozotocin-induced diabetic mice. Perforated silicone wound chambers containing a strip of polyvinyl alcohol sponge were implanted along the flanks of normal and diabetic mice. Wound fluid aspirated from the chambers 1, 3, and 7 days following implantation was analyzed for the total number of leukocytes and TNF and IL-6 levels. While the number of leukocytes in the wound fluid was similar on Days 1 and 3 following implantation, there were significantly fewer inflammatory cells in wound fluid from diabetic animals (13.8 × 106/ml) than in wound fluid from normal animals (28.5 × 106/ml) on Day 7 following implantation. TNF levels in the cell-free exudate fluid were similar between the two groups on all days examined. IL-6 levels were similar on Days 1 and 3 following implantation between the two groups, but there was significantly more IL-6 in wound fluid from normal animals (10,998 U/ml) than in wound fluid from diabetic animals (2096 U/ml) on Day 7 following implantation. Histologic evaluation of chambers 8 days following implantation revealed decreased neovascularization and less organization of granulation tissue. These data suggest that delayed healing in diabetes is associated with altered leukocyte infiltration and wound fluid IL-6 levels during the late inflammatory phase of wound healing.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Surgical Research
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Decreased collagen production in diabetic rats.Diabetes. 1988; 37: 371
- Effects of experimental diabetes, uremia, and malnutrition on wound healing.Diabetes. 1987; 36: 295
- Wound collagen accumulation in obese hyperglycemic mice.Diabetes. 1986; 35: 491
- Direct inhibition of collagen production in vitro by diabetic rat serum.Metabolism. 1988; 37: 479
- Studies of wound healing in experimental diabetes mellitus.J. Surg. Res. 1977; 22: 221
- Cytokine production in a model of wound healing: The appearance of MIP-1, MIP-2, cachectin/TNF and IL-1.Cytokine. 1990; 2: 92
- Characterization of wound cytokines in the sponge matrix model.Arch. Surg. 1989; 124: 1422
- Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α.Nature. 1987; 329: 630
- Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1 and epidermal growth factor in human fibroblasts.J. Cell. Physiol. 1987; 132: 271
- The biology of interleukin 6.Blood. 1989; 74: 1
- A subcutaneous implant for wound healing studies in humans.J. Surg. Res. 1986; 40: 229
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays.J. Immunol. Methods. 1983; 65: 55
- The influence of experimental diabetes and insulin treatments on the biomechanical properties of rat skin incisional wounds.Acta Chir. Scand. 1987; 153: 405
- Wound collagenase activity correlates directly with collagen glycosylation in diabetic rats.J. Pediatr. Surg. 1990; 25: 75
- Wound healing and the diabetic patient.Surg. Gynecol. Obstet. 1979; 149: 600
- Wound healing with diabetes mellitus: Better glucose control for better wound healing in diabetes.Surg. Clin. North Am. 1984; 64: 769
- Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus.N. Engl. J. Med. 1971; 284: 621
- Inhibition of leukocyte chemotaxis by a factor in alloxan-induced diabetic rat plasma.Diabetes. 1987; 36: 1307
- Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: Selective depression of cell responses mediated by complement-derived chemoattractants.Agents Actions. 1990; 30: 369
- The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus.J. Lab. Clin. Med. 1964; 64: 1
- Studies of the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis.J. Exp. Med. 1966; 124: 227
- Selective effects of tumor necrosis factor-α on wound healing in rats.Surgery. 1989; 106: 171
- Factors influencing blood supply in wound granulomas quantitated by a new in vivo technique.Cancer Res. 1989; 49: 415
- High glucose prolongs cell-cycle traversal of cultured human endothelial cells.Diabetes. 1987; 36: 1261
Presented at the Annual Meeting of the Association for Academic Surgery, Houston, Texas, November 14–17, 1990
© 1991 Published by Elsevier Inc.